Navigation Links
Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis

elopment of CellCept in autoimmune indications; and our two phase III clinical programs underway with CellCept: lupus nephritis and pemphigus vulgaris.

With respect to the forward-looking statements contained in this news release, we have made numerous assumptions regarding, among other things: our ability to predict the effects of CellCept on patients; our ability to continue our two phase III clinical programs underway with CellCept: lupus nephritis and pemphigus vulgaris; our ability to protect our intellectual property rights and to not infringe on the intellectual property rights of others; our ability to comply with applicable governmental regulations and standards; and our ability to succeed at establishing a successful commercialization program for any of our potential products. Readers are cautioned that the plans, intentions or expectations disclosed in any forward-looking statements and underlying assumptions may not be achieved and that they should not place undue reliance on any forward-looking statement. Actual results or events could differ materially from the plans, intentions, expectations, and assumptions expressed or implied in any forward-looking statements as a result of numerous risks, uncertainties and other factors, including those relating to: difficulties or delays in the progress, timing and results of clinical trials and studies; difficulties or delays in obtaining regulatory approvals; the FDA may determine that the design and planned analysis of our clinical trials do not adequately address the trial objectives in support of our regulatory submission; future sales of CellCept may be less than expected; our future operating results are uncertain and likely to fluctuate; we may not be able to develop and obtain regulatory approval for CellCept in the treatment of autoimmune indications and any future products in our targeted indications; we may not be able to establish marketing and sales capabilities and the costs of launching Cel
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:5/21/2013)...   Regulus Therapeutics Inc . ( NASDAQ: RGLS ... of innovative medicines targeting microRNAs, today announced that ... Officer and Executive Vice President, Finance, will present a ... Conference on Wednesday, May 29, 2013 at 3:30 pm ... Boston Waterfront Hotel. The presentation will be ...
(Date:5/21/2013)... , May 21, 2013 On ... impressive new product developments at the Special Libraries Association PHTD ... of unerring focus on product literature databases and workflow solutions ... the occasion," said founding director Nigel Johnson ... of benefit to our clients and what better forum to ...
(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...
Breaking Medicine Technology:Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2
... N.J., April 8, 2011 Unity Management Group, ... a Health Resource Company specializing in Physician, and ... Technologies, along with Pharmacy Instrumentation, Calibration, Data Acquisition, ... Inc. ("UNITY") (OTCMARKETS: UYMG) announced today it has ...
... 8, 2011 Xeridiem™ Medical Devices (xeridiem) is ... Excellence Award (MDEA).  This international award was for ... Clearance System (PleuraFlow ATC), developed by Clear Catheter ... the design and development for manufacturability, supported the ...
Cached Medicine Technology:Unity Management Group, Inc. MCC Receives First Major Order for B&D Italia Tablet Press 2Unity Management Group, Inc. MCC Receives First Major Order for B&D Italia Tablet Press 3Xeridiem Medical Devices Receives MD+DI 2011 Medical Design Excellence Award (MDEA). 2
(Date:5/21/2013)... of the adenoids and tonsils, is performed 500,000 times ... treatment for children with obstructive sleep apnea. However, ... executive functioning, behavior, sleep apnea symptoms, and quality of ... A study led by Susan Redline, MD, MPH, ... and Associate Clinic Director of the Division of Sleep ...
(Date:5/21/2013)... Harbor, Florida (PRWEB) May 21, 2013 ... agency, announced today that they have redesigned their website ... a nude beach, pool, hot tubs, bars and dining. ... this nudist resort including sales and guest reviews, will ... island of Jamaica itself, including pages on culinary local ...
(Date:5/21/2013)... 2013 The American Diabetes Association ( ... the United States of America are affected with peripheral ... great risk of developing peripheral neuropathy which unfortunately makes ... ADA further goes on saying that the disease usually ... 2 million new cases are diagnosed every year in ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Aggressive treatment ... many older patients with underlying medical conditions, a ... such as surgery, radiation and radioactive seed implants, ... dysfunction, urinary incontinence and bowel problems, explained researchers ... They found that older patients with ...
(Date:5/21/2013)... president for research and economic development will urge ... generation of supercomputers designed to tackle complex societal ... , Daniel Reed will appear at a hearing ... on Energy, titled, "America,s Next Generation Supercomputer: The ... in Room 2318 of the Rayburn House Office ...
Breaking Medicine News(10 mins):Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2Health News:Iowa VP for Research addresses next-generation supercomputers at congressional hearing 2
... RECEIVES EXCLUSIVE U.S. RIGHTS AND WILL RECEIVE A ROYALTY ON ... 19 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX: ... restructured its agreement with Novartis Pharma AG ("Novartis") to simplify ... among other things, receive exclusive U.S. rights to the Visudyne(R) ...
... Vancouver ... named as one of the Top Employers in BC for 2010. The annual list ... including employee benefits, community involvement and work atmosphere. , ... Vancouver, B.C. (Vocus) October 19, 2009 -- Vancouver based ...
... , ... expert, Dr. Matthew Loop, launches a new, first-of-a-kind club aimed at helping fellow chiropractors ... ... 2009 -- Matthew Loop, DC is proud to announce the release of a new, ...
... In her new ... the company - from facilities in Rhode Island to those in Hawaii. , ... Cleveland, TN (Vocus) October 18, 2009 -- ... president of interior design. ,    ,Neiman most recently served as one of Life Care,s interior ...
... congenita (DKC) is an autosomal dominant disease that leads to ... skin, nails, bone marrow, lungs and gut. Patients with DKC ... of fatal infections and cancer. Many die before the age ... trying to treat its symptoms. At the heart of DKC ...
... Homecare providers and their clients from across the state will ... tomorrow morning in advance of a court hearing on a ... disabled from losing critical in-home care services. , Advocates for ... UDW Homecare Providers Union (AFSCME Local 3930) and ...
Cached Medicine News:Health News:QLT restructures Visudyne(R) agreement 2Health News:QLT restructures Visudyne(R) agreement 3Health News:QLT restructures Visudyne(R) agreement 4Health News:Clearlycontacts.Ca Named as One of Bc's Top Employers 2Health News:Clearlycontacts.Ca Named as One of Bc's Top Employers 3Health News:Chiropractic Marketing Online Coach Launches First-of-a-Kind Wealth Club for Chiropractors 2Health News:Neiman Named Life Care's Vice President of Interior Design 2Health News:Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy 2Health News:Homecare Recipients and Providers to Rally against Cuts in IHSS Program; Hearing on Lawsuit in Oakland Federal Court Monday 2
... are becoming very popular only a few ... the pack. Explore why MediTalk is rapidly ... and practice administrators. An EMR designed by ... doctors see patients quickly and efficiently while ...
Transfer your exams to AltaPoint with our EMR Exam Word Lists. Document systems as normal and annotate exceptions to the systems in the exam. AltaPoint EMR is configured to allow a specialty to cust...
MediNotes e is an EMR design which utilizes a "tab concept for navigation. MediNotes e can display multiple patients, encounter notes, workflow items, patient flow, messages, alerts, and more, all in...
... Software developed a touchscreen EHR and is ... a user can choose to use a ... maintain eye contact while recording encounter results. ... EHR also runs on a pen tablet ...
Medicine Products: